ĀÜĄņĀŅĀ×

The Research and Development team at Enara Bio focuses on discovering and characterizing novel immunotherapy targets for cancer treatment. This multidisciplinary team leverages their expertise in immunopeptidomics, molecular immunology, cell process development, and bioinformatics to explore unconventional targets such as MR1-presented ligands and Dark Antigensā„¢. Their work involves identifying and validating these novel targets, advancing preclinical research, and ultimately contributing to the development of next-generation cancer immunotherapies.